Recce Pharmaceuticals Ltd (ASX:RCE)

Recce Pharmaceuticals Revenue

In the fiscal year ending June 30, 2026, Recce Pharmaceuticals had annual revenue of 9.47M AUD with 26.06% growth. Recce Pharmaceuticals had revenue of 9.05M in the half year ending June 30, 2026, with 242.04% growth. That makes Recce Pharmaceuticals the 39,122nd largest company in the world by revenue and 733rd in Australia.

• Revenue: 9.47M
• Revenue Growth: +26.06%
• P/S Ratio: 10.66
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 100.90M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Australia 7.36M 74.0%
• USA 1.97M 19.9%
• Unallocated 561.33K 5.6%
• UK 43.45K 0.4%

Fiscal year ended Jun 30, 2026 See the full Recce Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	9.47M	1.96M	26.06%
Jun 30, 2025	7.51M	2.48M	49.33%
Jun 30, 2024	5.03M	663.14K	15.19%
Jun 30, 2023	4.37M	1.28M	41.50%
Jun 30, 2022	3.08M	1.45M	88.41%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 6, 2026

Data Sources Report a data error